Mark Smith
Directeur/Bestuurslid bij Freya Biosciences ApS
Vermogen: 142 092 $ op 30-04-2024
Actieve functies van Mark Smith
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Freya Biosciences ApS
 Freya Biosciences ApS Miscellaneous Commercial ServicesCommercial Services Freya Biosciences ApS is a clinical-stage biotech company based in Copenhagen, Denmark, that is dedicated to advancing women's reproductive health. The Danish company focuses on reproductive microbial immunotherapy interventions to improve fertility outcomes and empower women with innovative solutions. Freya Biosciences aims to address immune drivers underlying a range of reproductive health conditions to create a future where everyone is empowered with optimal reproductive health. The company was founded by Johan van Hylckama Vlieg, Colleen Acosta, Randi Rich, and Ulrich Binné, and Colleen Acosta has been the CEO since incorporation. | Directeur/Bestuurslid | - | - |
Loopbaan van Mark Smith
Eerdere bekende functies van Mark Smith
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Directeur/Bestuurslid | 01-09-2017 | 15-05-2023 |
| Algemeen Directeur | 01-09-2017 | 15-05-2023 | |
| Oprichter | 01-09-2017 | 15-05-2023 | |
The Microbiome Health Research Institute, Inc.
 The Microbiome Health Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Microbiome Health Research Institute, Inc. operates a public stool bank. It specializes in stool preparations to clinicians for fecal microbiota transplantation and to catalyse research into the human microbiome. The company was founded by James Burgess and Mark Smith in 2012 and is headquartered in Somerville, MA. | Directeur/Bestuurslid | 01-01-2012 | 01-07-2016 |
| Hoofd Techniek/Wetenschap/O&O | 01-01-2012 | 01-07-2016 | |
| Oprichter | 01-01-2012 | 01-07-2016 | |
| President | 01-01-2012 | 01-07-2016 |
Opleiding van Mark Smith
| Massachusetts Institute of Technology | Doctorate Degree |
| Princeton University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Denemarken | 2 |
Operationeel
| Director/Board Member | 3 |
| Founder | 2 |
| Chief Executive Officer | 1 |
Sectoraal
| Commercial Services | 3 |
| Finance | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Health Services |
| Bedrijven in privébezit | 2 |
|---|---|
The Microbiome Health Research Institute, Inc.
The Microbiome Health Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Microbiome Health Research Institute, Inc. operates a public stool bank. It specializes in stool preparations to clinicians for fecal microbiota transplantation and to catalyse research into the human microbiome. The company was founded by James Burgess and Mark Smith in 2012 and is headquartered in Somerville, MA. | Commercial Services |
Freya Biosciences ApS
Freya Biosciences ApS Miscellaneous Commercial ServicesCommercial Services Freya Biosciences ApS is a clinical-stage biotech company based in Copenhagen, Denmark, that is dedicated to advancing women's reproductive health. The Danish company focuses on reproductive microbial immunotherapy interventions to improve fertility outcomes and empower women with innovative solutions. Freya Biosciences aims to address immune drivers underlying a range of reproductive health conditions to create a future where everyone is empowered with optimal reproductive health. The company was founded by Johan van Hylckama Vlieg, Colleen Acosta, Randi Rich, and Ulrich Binné, and Colleen Acosta has been the CEO since incorporation. | Commercial Services |
- Beurs
- Insiders
- Mark Smith
- Ervaring